Results from an open‐label extension study of etanercept in ankylosing spondylitis

This publication has 4 references indexed in Scilit:

• Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial
  Arthritis & Rheumatism, 2003
• Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor α
  New England Journal of Medicine, 2002
• Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
  The Lancet, 2002
• A six‐month randomized, controlled, double‐blind, dose‐response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug–refractory ankylosing spondylitis
  Arthritis & Rheumatism, 2002